Lipocine Inc. (LPCN)
NASDAQ: LPCN
· Real-Time Price · USD
3.11
-0.01 (-0.38%)
At close: Jun 06, 2025, 3:59 PM
3.02
-2.89%
After-hours: Jun 06, 2025, 04:21 PM EDT
Lipocine Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Royalty Revenue | 298.14K |
| Royalty Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.12M | 873.05K | 1.05M | 1.51M | 1.58M | 1.13M | 1.04M | 1.44M | 1.29M | 890.34K | 798.94K | 1.13M | 1.24M | 1.05M | 1.22M | 1.53M | 1.53M | 2.32M | 1.89M | 1.95M | 2.09M | 1.61M | 1.43M | 1.39M | 1.18M | 989.48K | 930.14K | 1.68M | 1.69M | 3.64M | 2.72M | 2.03M | 1.83M | 1.34M | 1.39M | 3.25M | 4.4M | 1.93M | 1.7M | 1.12M | 1.06M |
| Selling, General, and Administrative Revenue Growth | +28.57% | -16.47% | -30.66% | -4.33% | +38.88% | +8.83% | -27.62% | +11.89% | +44.59% | +11.44% | -29.27% | -9.18% | +18.66% | -14.24% | -19.89% | -0.55% | -33.93% | +23.03% | -3.40% | -6.32% | +29.73% | +12.62% | +2.94% | +17.90% | +18.84% | +6.38% | -44.70% | -0.32% | -53.58% | +33.67% | +33.72% | +11.43% | +35.87% | -3.66% | -57.06% | -26.14% | +127.78% | +13.54% | +52.36% | +5.71% | n/a |
| Research and Development Revenue | 1.06M | 1.06M | 1.59M | 1.87M | 2.82M | 1.67M | 2.88M | 2.52M | 3.11M | 1.67M | 2.1M | 2.9M | 1.89M | 2.25M | 2.37M | 1.46M | 1.58M | 2.48M | 2.49M | 2.27M | 2.51M | 1.84M | 1.71M | 1.96M | 1.95M | 2.18M | 1.42M | 1.48M | 1.38M | 1.77M | 2.05M | 4.11M | 3.08M | 1.33M | 1.51M | 2.57M | 2.67M | 2.77M | 4.73M | 3.16M | 1.92M |
| Research and Development Revenue Growth | +0.40% | -33.30% | -15.44% | -33.50% | +68.30% | -41.82% | +14.46% | -19.03% | +85.95% | -20.47% | -27.52% | +53.50% | -16.23% | -4.76% | +61.57% | -7.33% | -36.27% | -0.32% | +9.65% | -9.67% | +36.45% | +7.44% | -12.77% | +0.73% | -10.64% | +53.34% | -4.01% | +7.61% | -22.05% | -13.65% | -50.17% | +33.18% | +132.14% | -11.83% | -41.33% | -3.95% | -3.34% | -41.58% | +49.72% | +64.79% | n/a |